Malaysian pharmaceutical firm Duopharma Biotech Berhad has signed a deal with the Russian investment fund behind Sputnik V to supply more than six million doses of the jab. RT speaks to the company’s chief operating officer, Wan Jeffery Majid, about whether to expect local production of the Russian vaccine in Malaysia, and why his company chose Sputnik V.
Subscribe to RT! https://www.youtube.com/channel/UCpwvZwUam-URkxB7g4USKpg?sub_confirmation=1
RT LIVE https://www.youtube.com/watch?v=IFAcqaNzNSc
Check out http://rt.com
Like us on Facebook http://www.facebook.com/RTnews
Follow us on VK https://vk.com/rt_international
Follow us on Twitter http://twitter.com/RT_com
Follow us on Instagram http://instagram.com/rt
Follow us on Soundcloud https://soundcloud.com/rttv
Follow us on Telegram https://t.me/rtintl
#RT (Russia Today) is a global #news network broadcasting from Moscow, London, Paris and Washington studios to over 100 countries. RT is the first news channel to break the 1 billion YouTube views benchmark.
Subscribe to RT! https://www.youtube.com/channel/UCpwvZwUam-URkxB7g4USKpg?sub_confirmation=1
RT LIVE https://www.youtube.com/watch?v=IFAcqaNzNSc
Check out http://rt.com
Like us on Facebook http://www.facebook.com/RTnews
Follow us on VK https://vk.com/rt_international
Follow us on Twitter http://twitter.com/RT_com
Follow us on Instagram http://instagram.com/rt
Follow us on Soundcloud https://soundcloud.com/rttv
Follow us on Telegram https://t.me/rtintl
#RT (Russia Today) is a global #news network broadcasting from Moscow, London, Paris and Washington studios to over 100 countries. RT is the first news channel to break the 1 billion YouTube views benchmark.
- Category
- Europe
- Tags
- RT, Russia Today, happening now
Sign in or sign up to post comments.
Be the first to comment